Related Experiment Video

Updated: Jul 10, 2025

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

10.9K

Necroptosis inhibitors: mechanisms of action and therapeutic potential

Yingbo Zhou1, Zhangtao Cai1, Yijia Zhai1

  • 1School of Medicine, Tongji University, Shanghai, 200092, China.

Apoptosis : an International Journal on Programmed Cell Death
|November 24, 2023
PubMed

Insights

Necroptosis, a programmed cell death pathway, is implicated in numerous diseases. Inhibitors targeting key proteins like RIPK1, RIPK3, and MLKL offer therapeutic potential for these conditions.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Necroptosis is a regulated form of cell death resembling necrosis.
  • It plays a role in inflammatory, neurodegenerative, infectious, and malignant diseases.
  • Key signaling pathway components include RIPK1, RIPK3, and MLKL.

Purpose of the Study:

  • To review recent advancements in necroptosis inhibitors.
  • To explore their mechanisms of action.
  • To discuss their therapeutic applications in disease treatment.

Main Methods:

  • Literature review of necroptosis inhibitor research.
  • Analysis of signaling pathway components (RIPK1, RIPK3, MLKL).
  • Evaluation of inhibitor efficacy and disease relevance.

Main Results:

  • Identification of RIPK1, RIPK3, and MLKL as crucial targets.
  • Development of various necroptosis inhibitors.
  • Demonstration of inhibitors' potential in preclinical models.

Conclusions:

  • Necroptosis inhibitors are valuable tools for understanding the pathway.
  • These inhibitors represent promising drug candidates for necroptosis-related diseases.
  • Further research is warranted to translate findings into clinical treatments.
Keywords:
InhibitorsMLKLNecroptosisRIPK1RIPK3

More Related Videos

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells09:15

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells

Published on: October 20, 2022

2.2K
Peptide-based Identification of Functional Motifs and their Binding Partners14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

12.5K

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.5K